September 14, 2020
UC San Diego Health continues to expand health care services by opening a new clinic located at 6030 Village Way in Pacific Highlands Ranch. The clinic offers primary care and women’s health services.
April 19, 2023
Khristiane “Frances” Reyes credits a trip to the Philippines and a multidisciplinary team at UC San Diego Health for saving his life.
September 8, 2022
After a rare disease caused organ failure, UC San Diego Heath transplant teams performed a heart, liver and kidney transplant on a patient. The surgery is a first for UC San Diego Health and a first in the nation to use three organs from a donor after circulatory death.
February 11, 2019
The Adult Congenital Heart Disease Program at UC San Diego Health is the only one in the region to provide a multi-disciplinary team with extensive knowledge in congenital heart disease and help patients transition from pediatric care to adult care.
April 12, 2023
Pablo Velez, RN, PhD, has been appointed by UC San Diego Health as ECRMC’s chief executive officer effective April 17.
September 18, 2024
UC San Diego Health ranks among the top academic medical centers for quality in Vizient’s 2024 Bernard A. Birnbaum Quality Leadership Award.
September 10, 2012
Structural and mechanical engineers at the University of California, San Diego, are working together to create blood flow simulations that could lead to improvements in the design of a cardiac pump for children born with heart defects. They hope that the design changes will improve young patients’ outcomes.
September 26, 2024
Patient undergoes 5,000th innovative surgery by a multidisciplinary team at UC San Diego Health to remove blood clots from the lung’s paper-thin arteries.
November 26, 2019
The Achievement Rewards for College Scientists (ARCS) Foundation has awarded a total of $225,000 to 30 graduate students at the University of California San Diego for the 2019-20 academic year.
September 11, 2019
Ventrix, a University of California San Diego spin-off company, has successfully conducted a first-in-human, FDA-approved Phase 1 clinical trial of an injectable hydrogel that aims to repair damage and restore cardiac function in heart failure patients who previously suffered a heart attack.
